Literature DB >> 9729545

A serotyping assay for hepatitis C virus in Southeast Asia.

S Songsivilai1, D Kanistanon, T Dharakul.   

Abstract

A serotyping assay for hepatitis C virus (HCV) was evaluated with samples from Thailand, where the distribution of HCV genotypes was different from that in Western countries where the assay was designed and validated. The sensitivity of the assay was low (58%) for HCV RNA-positive samples compared to that of the genotyping assay (95%, P < 0.01). In addition, only 36% of anti-HCV-positive but HCV RNA-negative samples could be serotyped. The serotypes and genotypes were identical in 96% of the samples that could be typed by both methods. Most of the samples with genotype 6, which was common in Southeast Asia, were nontypeable by this serotyping assay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729545      PMCID: PMC95649          DOI: 10.1128/CDLI.5.5.737-739.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  14 in total

1.  Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

Authors:  V Bhattacherjee; L E Prescott; I Pike; B Rodgers; H Bell; A R El-Zayadi; M C Kew; J Conradie; C K Lin; H Marsden
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

Review 2.  Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.

Authors:  J Bukh; R H Miller; R H Purcell
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

3.  Correlation between serological and genetic methods for typing hepatitis C virus.

Authors:  L Montesano; M Gutiérrez; R Bravo; M Baquero; V Soriano
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

4.  Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay.

Authors:  S Navas; I Castillo; J Martín; J A Quiroga; J Bartolomé; V Carreño
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 5.  Factors predictive of a beneficial response to therapy of hepatitis C.

Authors:  G L Davis; J Y Lau
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Genotypic distribution of hepatitis C virus in different regions of Thailand.

Authors:  D Kanistanon; M Neelamek; T Dharakul; S Songsivilai
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

7.  Analysis of hepatitis C virus isolates by serotyping and genotyping.

Authors:  L J van Doorn; B Kleter; I Pike; W Quint
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay.

Authors:  J Mellor; E A Walsh; L E Prescott; L M Jarvis; F Davidson; P L Yap; P Simmonds
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

9.  Serological reactivity and viral genotypes in hepatitis C virus infection.

Authors:  F Maggi; M L Vatteroni; M Pistello; C M Avio; N Cecconi; F Panicucci; M Bendinelli
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

View more
  1 in total

Review 1.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.